Orum Therapeutics Grants Stock Options for 108,500 Shares to Five Recipients
Bitget2026/10/23 08:29- Orum Therapeutics granted stock options covering 108,500 common shares to five recipients on October 23, 2026.
- Director Geoffrey Harris Meyerson received options covering 22,837 shares, exercisable from October 24, 2028, through October 23, 2031.
- Four US subsidiary employees received options covering 85,663 shares, exercisable from October 24, 2028, through October 23, 2036.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like

Jensen Huang's influence surpasses that of Nvidia— and that's exactly the problem
Jensen Huang has been the key driving force behind the massive expansion of AI infrastructure, with his personal credibility and authoritative decision-making deeply embedded in the narrative of the global tech market’s rise over the past three years. Now, as scandals emerge, Nvidia’s trading team is expected to become more conservative and slow down external financing commitments, which undoubtedly worsens the situation for neoclouds already facing tight funding.

